Inti Zlobec
Inti Zlobec
Unknown affiliation
Verified email at pathology.unibe.ch
Title
Cited by
Cited by
Year
Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ...
The Journal of pathology 232 (2), 199-209, 2014
8892014
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10 (1), 1-10, 2012
6292012
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
5702018
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey, C Nebiker, X Huber, I Zlobec, ...
European journal of cancer 49 (9), 2233-2242, 2013
3422013
High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients
DM Frey, RA Droeser, CT Viehl, I Zlobec, A Lugli, U Zingg, D Oertli, ...
International Journal of Cancer 126 (11), 2635-2643, 2010
2972010
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
A Lugli, R Kirsch, Y Ajioka, F Bosman, G Cathomas, H Dawson, ...
Modern pathology 30 (9), 1299-1311, 2017
2952017
Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’pathway to colorectal cancer
JR Jass, K Baker, I Zlobec, T Higuchi, M Barker, D Buchanan, J Young
Histopathology 49 (2), 121-131, 2006
2842006
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
A Lugli, G Iezzi, I Hostettler, MG Muraro, V Mele, L Tornillo, V Carafa, ...
British journal of cancer 103 (3), 382-390, 2010
2742010
Clinicopathological and protein characterization of BRAF‐and K‐RAS‐mutated colorectal cancer and implications for prognosis
I Zlobec, MP Bihl, H Schwarb, L Terracciano, A Lugli
International journal of cancer 127 (2), 367-380, 2010
2652010
Prognostic and predictive factors in colorectal cancer
I Zlobec, A Lugli
Postgraduate medical journal 84 (994), 403-411, 2008
2532008
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget
I Zlobec, A Lugli
Oncotarget 1 (7), 651, 2010
2382010
Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles
P Minoo, I Zlobec, M Peterson, L Terracciano, A Lugli
International journal of oncology 37 (3), 707-718, 2010
2312010
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
CA Fischer, I Zlobec, E Green, S Probst, C Storck, A Lugli, L Tornillo, ...
International journal of cancer 126 (5), 1256-1262, 2010
2082010
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer
I Zlobec, R Steele, L Terracciano, JR Jass, A Lugli
Journal of clinical pathology 60 (10), 1112-1116, 2007
2052007
Disordered eating behaviors in type 1 diabetic patients
A Larrañaga, MF Docet, RV García-Mayor
World journal of diabetes 2 (11), 189, 2011
190*2011
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer
P Minoo, I Zlobec, K Baker, L Tornillo, L Terracciano, JR Jass, A Lugli
American journal of clinical pathology 127 (5), 820-827, 2007
1602007
Tumor budding in colorectal cancer—ready for diagnostic practice?
VH Koelzer, I Zlobec, A Lugli
Human pathology 47 (1), 4-19, 2016
1442016
Tumour budding: a promising parameter in colorectal cancer
A Lugli, E Karamitopoulou, I Zlobec
British journal of cancer 106 (11), 1713-1717, 2012
1442012
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters
CA Fischer, M Kampmann, I Zlobec, E Green, L Tornillo, A Lugli, ...
Annals of oncology 21 (10), 1961-1966, 2010
1422010
HER2gene status in primary breast cancers and matched distant metastases
C Tapia, S Savic, U Wagner, R Schönegg, H Novotny, B Grilli, M Herzog, ...
Breast Cancer Research 9 (3), R31, 2007
1412007
The system can't perform the operation now. Try again later.
Articles 1–20